van Hoogdalem P, Donker A J, Brentjens J R, van der Hem G K, Oosterhuis J W
Acta Med Scand. 1977;201(4):395-9. doi: 10.1111/j.0954-6820.1977.tb15719.x.
This case report describes a patient with malignant hypertension and phaeochromocytoma in whom blockade of angiotensin II receptors by the competitive antagonist 1-sar-8-ala-angiotensin II (Saralasin) resulted in a partial correction of the elevated BP. Plasma renin activity was high and rose further during the blockade. Competitive inhibition of angiotensin II by Saralasin does not abolish the pressor effect of catecholamines. It was therefore interesting to observe that in this patient with phaeochromocytoma, independently, both alpha-adrenergic receptor blockade and angiotensin II receptor blockade were effective in lowering BP.
本病例报告描述了一名患有恶性高血压和嗜铬细胞瘤的患者,竞争性拮抗剂1-肌氨酸-8-丙氨酸血管紧张素II(沙拉新)对血管紧张素II受体的阻断导致血压升高得到部分纠正。血浆肾素活性较高,在阻断过程中进一步升高。沙拉新对血管紧张素II的竞争性抑制并不能消除儿茶酚胺的升压作用。因此,有趣的是观察到,在这名嗜铬细胞瘤患者中,单独使用α-肾上腺素能受体阻断和血管紧张素II受体阻断均能有效降低血压。